Welcome to the Adoptive T-Cell Therapy Congress

The Adoptive T-Cell Therapy Congress gathers thought leaders from biotech, big pharma, academia and the wider service community to discuss progress and share insight on strategies – including Car-T, TILS and TCR – that are critical to furthering the development of viable T-cell therapies.

Key session topics include: 

  • Advancements in T-cell engineering
  • Efficacy in different cancer models
  • Results from human and clinical studies
  • Commercialisation of Viable T-cell therapies
  • Scaling and manufacture of T-cells

Join us for a rare opportunity to hear first-hand from those with case studies on real patients and insight on solid tumours. Get involved today.

2016 Featured Speakers

file-img
Download the
Programme
register-blue-button
spyglass-img
Apply for a Poster
Session
download-blue-btn
spyglass-img
Register for a
Delegate Pass
download-blue-btn
handshake-img
Find out Sponsorship
Opportunities
download-blue-btn

2016 Sponsors:

2016 Media Partners:

BioProcess InternationalCellTherapyNewsEPR LOGO_Blackgenetherapynetbanner234x60 - gifHuman Gene Therapy logo
HumanImmunologyNewsImmuneRegulationNewsIMT-logoDrug taget review Logo-01
Are you currently studying or working
at a University, as an active Clinician
or in Post-Doctoral Research?
Are you working within the Adoptive
T-Cell Therapy industry or have a
business interest in this market?